NAD+

INVESTIGATIONAL

Cellular energy and longevity coenzyme

By the INFOPEPTIDOS editorial team · content based on scientific literature.

Updated: August 2026.

NAD+ — Essential coenzyme (nicotinamide adenine dinucleotide) present in every cell. It is mainly researched for cellular energy, longevity, cognition and recovery. Typical dose: 50–100 mg subcutaneous (or 250–500 mg IV), in cycles. Not FDA-approved as a treatment (available as a supplement).
Typical dose
50-100 mg
Daily or every other day
Route
SC or IV
Subcutaneous or intravenous
Cycle
In cycles
Typical duration
Storage
2-8 °C
Refrigerated

Key points

Technical data: Molecular formula C21H27N7O14P2 · Molecular weight 663.4 g/mol. Source: PubChem.

Overview

What is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell and essential for energy production in the mitochondria. Its levels decline with age, and its replenishment is researched for possible effects on energy, longevity and cognitive function.

Key benefits

Support for cellular energy, DNA repair and the activity of sirtuins, proteins associated with longevity. Many users report more energy, mental clarity and better recovery.

Mechanism of action

NAD+ acts as an electron carrier in energy metabolism and as a substrate for sirtuins and DNA-repair enzymes. Replenishing NAD+ aims to counteract its age-related decline.

Quick start guide

Typical dose
50-100 mg (SC)
Frequency
Daily or every other day
Route
Subcutaneous or slow intravenous
Timing
Administer slowly to avoid discomfort
Effects timeline
Energy often within the first week
Storage
Refrigerate at 2-8 °C
Cycle length
Cycles of several weeks
Break between cycles
Depending on goal

Dosing protocol

RouteDoseFrequencyDuration
Subcutaneous50–100 mgDaily or every other dayIn cycles
Intravenous250–500 mg1–2 times/weekIn cycles

Administer slowly: fast infusion causes tightness and nausea. The specific dose must be assessed by a healthcare professional.

Reconstitution: units in the syringe

Example with a 500 mg vial + 5 ml of bacteriostatic water → a 100 mg/ml solution. On a U-100 insulin syringe (100 units = 1 ml):

DoseVolumeUnits (U-100)
50 mg0.50 ml50 U
100 mg1.00 ml100 U

Is your vial or water different? Calculate the exact units below.

🧮 Calculate your exact syringe dose →

⚠️ Who should NOT use it

What to expect

Side effects & safety

Frequently asked questions

What is NAD+?

It is a coenzyme essential for cellular energy whose levels decline with age; it is researched for longevity effects.

How is NAD+ administered?

Subcutaneously or by slow intravenous route; fast administration causes discomfort.

What is the NAD+ dose?

Around 50-100 mg subcutaneous or 250-500 mg IV, in cycles. The regimen is set by a professional.

What is NAD+ for?

It is researched for energy, longevity, recovery and cognitive function.

What are the side effects?

Mainly chest tightness and nausea when administration is too fast.

Is NAD+ approved?

It is not FDA-approved as a treatment, though it exists as a supplement.

Research areas

Related peptides

Related articles

Related topics

Summary

What it is: Cellular energy and longevity coenzyme.

How it is researched: SC 50-100 mg or IV 250-500 mg, in cycles.

Key features: Supports mitochondria and sirtuins. Not FDA-approved as a treatment.

Related peptides: Epitalon, Glutathione and MOTS-c.

References

  1. Bhasin S et al. (2023). Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns. Endocr Rev. PubMed · DOI
  2. Nadeeshani H et al. (2022). Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns. J Adv Res. PubMed · DOI
  3. Kang S et al. (2024). Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD(+)) by Synergistic Inhibition of CD38 Expression. Cells. PubMed · DOI
  4. Hosseini L et al. (2019). Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions. Biogerontology. PubMed · DOI

Studies compiled from PubMed for informational purposes; many are preclinical or research-stage and do not constitute medical advice.